1. Rothan HA, Byrareddy SN. The epidemiology and pathogenesis of coronavirus disease 2019 (COVID-19) outbreak. J Autoimmun. 2020; 109:102433. [
DOI:10.1016/j.jaut.2020.102433] [
PMID]
2. Kim GU, Kim MJ, Ra SH, Lee J, Bae S, Jung J, et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect. 2020; 26(7):948.e1-948.e3. [
DOI:10.1016/j.cmi.2020.04.040] [
PMID] [
PMCID]
3. Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020; 288(2):192-206. [
DOI:10.1111/joim.13091] [
PMID]
4. Tanaka H, Ogata T, Shibata T, Nagai H, Takahashi Y, Kinoshita M, et al. Shorter incubation period among COVID-19 cases with the BA.1 Omicron variant. Int J Environ Res Public Health. 2022; 19(10):6330. [
DOI:10.3390/ijerph19106330] [
PMID] [
PMCID]
5. Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-42. [
DOI:10.1001/jama.2020.2648] [
PMID]
6. Price-Haywood EG, Burton J, Fort D, Seoane L. Hospitalization and mortality among Black patients and White patients with COVID-19. N Engl J Med. 2020; 382(26):2534-43. [
DOI:10.1056/NEJMsa2011686] [
PMID]
7. Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16):1574-81. [
DOI:10.1001/jama.2020.5394] [
PMID]
8. Vardavas CI, Mathioudakis AG, Nikitara K, Stamatelopoulos K, Georgiopoulos G, Phalkey R, et al. Prognostic factors for mortality, intensive care unit and hospital admission due to SARS-CoV-2: a systematic review and meta-analysis of cohort studies in Europe. Eur Respir Rev. 2022; 31(166):220098. [
DOI:10.1183/16000617.0098-2022] [
PMID] [
PMCID]
9. Sarri G, Liu W, Zabotka L, Freitag A, Claire R, Wangge G, et al. Prognostic factors of COVID-19: an umbrella review endorsed by the International Society for Pharmacoepidemiology. Clin Pharmacol Ther. 2023; 114(3):604-13. [
DOI:10.1002/cpt.2977] [
PMID] [
PMCID]
10. Palacios-Moguel P, Esquivel-Pineda A, Flores-Andrade XA, Aguirre-Sanchez JS, Cruz-Arellanes NN, Sauza-Sosa JC, et al. Acute respiratory distress syndrome in patients with COVID-19 vs. non-COVID-19: clinical characteristics and outcomes in a tertiary care setting in Mexico City. BMC Pulm Med. 2023; 23(1):430. [
DOI:10.1186/s12890-023-02744-6] [
PMID] [
PMCID]
11. Nyberg T, Ferguson NM, Nash SG, Webster HH, Flaxman S, Andrews N, et al. Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study. Lancet. 2022; 399(10332):1303-12. [
DOI:10.1016/S0140-6736(22)00462-7] [
PMID]
12. Smith DRM, Duval A, Zahar JR, Opatowski L, Temime L; EMAE-MESuRS Working Group on Nosocomial SARS-CoV-2 Modelling. Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk. Nat Commun. 2022; 13(1):236. [
DOI:10.1038/s41467-021-27845-w] [
PMID] [
PMCID]
13. Jarrom D, Elston L, Washington J, Prettyjohns M, Cann K, Myles S, et al. Effectiveness of tests to detect the presence of SARS-CoV-2 virus, and antibodies to SARS-CoV-2, to inform COVID-19 diagnosis: a rapid systematic review. BMJ Evid Based Med. 2022; 27(1):33-45. [
DOI:10.1136/bmjebm-2020-111511] [
PMID]
14. World Health Organization. Diagnostic testing for SARS-CoV-2: interim guidance, 11 September 2020. Geneva: World Health Organization; 2020.
15. Sadiq Z, Rana S, Mahfoud Z, Raoof A. Systematic review and meta-analysis of chest radiograph (CXR) findings in COVID-19. Clin Imaging. 2021; 80:229-38. [
DOI:10.1016/j.clinimag.2021.06.039] [
PMID] [
PMCID]
16. Fu F, Lou J, Xi D, Bai Y, Ma G, Zhao B, et al. Chest computed tomography findings of coronavirus disease 2019 (COVID-19) pneumonia. Eur Radiol. 2020; 30(10):5489-98. [
DOI:10.1007/s00330-020-06920-8] [
PMID] [
PMCID]
17. Buttia C, Llanaj E, Raeisi-Dehkordi H, Kastrati L, Amiri M, Meçani R, et al. Prognostic models in COVID-19 infection that predict severity: a systematic review. Eur J Epidemiol. 2023; 38(4):355-72. [
DOI:10.1007/s10654-023-00973-x] [
PMID] [
PMCID]
18. de Jong VM, Rousset RZ, Antonio-Villa NE, Buenen AG, Van Calster B, Bello-Chavolla OY, et al. Clinical prediction models for mortality in patients with COVID-19: external validation and individual participant data meta-analysis. BMJ. 2022; 378:e069881. [
DOI:10.1136/bmj-2021-069881] [
PMID]
19. Struyf T, Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Leeflang MMG, et al. Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19. Cochrane Database Syst Rev. 2022; 5:CD013665. [
DOI:10.1002/14651858.CD013665.pub3] [
PMID]
20. Parekh M, Donuru A, Balasubramanya R, Kapur S. Review of the chest CT differential diagnosis of ground-glass opacities in the COVID era. Radiology. 2020; 297(3):e289-e302. [
DOI:10.1148/radiol.2020202504] [
PMID] [
PMCID]
21. World Health Organization. COVID-19 clinical management: living guidance, 25 January 2021. Geneva: World Health Organization; 2021.
22. Friedman J, Hastie T, Tibshirani R. Regularization paths for generalized linear models via coordinate descent. J Stat Softw. 2010; 33(1):1-22. [
DOI:10.18637/jss.v033.i01] [
PMID]
23. R Core Team. R: a language and environment for statistical computing. Version 3.6.3. Vienna: R Foundation for Statistical Computing; 2020.
24. Ritchie MD, Hahn LW, Roodi N, Bailey LR, Dupont WD, Parl FF, et al. Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet. 2001; 69(1):138-47. [
DOI:10.1086/321276] [
PMID] [
PMCID]
25. Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med. 2020; 173(4):262-7. [
DOI:10.7326/M20-1495] [
PMID]
26. Relan P, Motaze NV, Kothari K, Askie L, Le Polain O, Van Kerkhove MD, et al. Severity and outcomes of Omicron variant of SARS-CoV-2 compared to Delta variant and severity of Omicron sublineages: a systematic review and meta-analysis. BMJ Glob Health. 2023; 8(7):e012328. [
DOI:10.1136/bmjgh-2023-012328] [
PMID] [
PMCID]
27. Li LQ, Huang T, Wang YQ, Wang ZP, Liang Y, Huang TB, et al. COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis. J Med Virol. 2020; 92(6):577-83. [
DOI:10.1002/jmv.25757] [
PMID]
28. Wan S, Xiang Y, Fang W, Zheng Y, Li B, Hu Y, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020; 92(7):797-806. [
DOI:10.1002/jmv.25783] [
PMID] [
PMCID]
29. Talebi S, Nematshahi M, Tajabadi A, Khosrojerdi A. Comparison of clinical and epidemiological characteristics of deceased and recovered patients with COVID-19 in Sabzevar, Iran. J Mil Med. 2020; 22(6):509-16.
30. Norooznezhad AH, Najafi F, Riahi P, Moradinazar M, Shakiba E, Mostafaei S. Primary symptoms, comorbidities, and outcomes of 431 hospitalized patients with confirmative RT-PCR results for COVID-19. Am J Trop Med Hyg. 2020; 103(2):834-7. [
DOI:10.4269/ajtmh.20-0512] [
PMID] [
PMCID]
31. Gholampour Y, Tehranineshat B, Najafi H, Farjam M, Rahimi Z, Bijani M. A study of demographic characteristics, clinical manifestations, radiologic and laboratory findings of patients hospitalized with COVID-19 in the south of Iran. J Fasa Univ Med Sci. 2020; 10(3):2456-65.
32. Richardson S, Hirsch JS, Narasimhan M, Crawford JM, McGinn T, Davidson KW, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323(20):2052-9. [
DOI:10.1001/jama.2020.6775] [
PMID]
33. Clerkin KJ, Fried JA, Raikhelkar J, Sayer G, Griffin JM, Masoumi A, et al. COVID-19 and cardiovascular disease. Circulation. 2020; 141(20):1648-55. [
DOI:10.1161/CIRCULATIONAHA.120.046941] [
PMID]
34. Eghdampanah Foumani T, Kamyari N, Shadrvan MM, Khishvand F, Shahroud Dezful F, Kanani K, et al. Evaluation of diagnostic markers in neurological patients with COVID-19. J Med Microbiol Infect Dis. 2026; 14(1):17-23.
35. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-62. [
DOI:10.1016/S0140-6736(20)30566-3]
36. Bager P, Wohlfahrt J, Bhatt S, Stegger M, Legarth R, Møller CH, et al. Risk of hospitalisation associated with infection with SARS-CoV-2 omicron variant versus delta variant in Denmark: an observational cohort study. Lancet Infect Dis. 2022; 22(7):967-76. [
DOI:10.1016/S1473-3099(22)00154-2] [
PMCID]
37. Goodarzi E, Kakavand MR, Rashidi K, Mamdohi SH, Momenabadi V, Navabi M, et al. Paraclinical characteristics of fatal and recovered COVID-19 cases: a retrospective study. J Med Microbiol Infect Dis. 2022; 10(2):80-6. [
DOI:10.52547/JoMMID.10.2.80]
38. Abodunrin OR, Olagunju MT, Huang X, Wang J, Hu Z, Shen C. Regional risk factors associated with adverse outcomes of COVID-19 infection among the older adult: a systematic review and meta-analysis. J Infect Public Health. 2025; 18(2):102632. [
DOI:10.1016/j.jiph.2024.102632] [
PMID]